Position in NVCR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,014
New position
Shares Held
397
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#184
of 214 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hurley Capital, LLC holds $125,211 across 11 Medical Devices names. NVCR ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
230 | $72,622 | |
| 2 | BSX |
Boston Scientific Corp
|
445 | $18,992 | |
| 3 | ABT |
Abbott Laboratories
|
104 | $9,436 | |
| 4 | NVCR |
NovoCure Ltd
This page
|
397 | $6,014 | |
| 5 | CLPT |
ClearPoint Neuro, Inc.
|
330 | $5,887 | |
| 6 | PACB |
Pacific Biosciences Of California, Inc.
|
2,976 | $4,999 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
48 | $4,132 | |
| 8 | NNOX |
Nano-X Imaging Ltd.
|
1,133 | $1,314 |
All Filings in NVCR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,014 | 397 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||